The untreated membranes displayed signs of nanoclay fouling much more quickly than the LGMs, and the LGMs were able to filter water three times longer than the standard membranes before requiring a “backwash” procedure to remove particles that had accumulated on the membrane. Less frequent backwashing could translate to a reduction in the use of cleaning chemicals and energy required to pump backwash water, and improve the filtration rate in industrial water treatment settings.

While the LGMs did eventually experience fouling, 60 percent less nanoclay accumulated in their structures during filtration, an accumulation known as “irreversible fouling” because it is not removed by backwashing. This advantage gives LGMs a longer lifespan and makes more of the filtrate recoverable for alternate uses. Additionally, the LGMs required 16 percent less pressure to initiate filtration, adding to the energy savings.

“LGMs have the potential for use in industries as diverse as food and beverage processing, biopharmaceutical manufacturing, textiles, paper, pulp, chemical, and petrochemical, and could offer improvements in energy use and efficiency across a wide swath of industrial applications,” said corresponding author Joanna Aizenberg, who is a founding core faculty member of the Wyss Institute and the Amy Smith Berylson Professor of Material Sciences at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS).

The team’s next steps for the research include larger-scale pilot studies with industry partners, longer-term operation of the LGMs, and filtering even more complex mixtures of substances. These studies will provide insight into the commercial viability of LGMs for different applications, and how long they would last in a number of uses.

“The concept of using a liquid to help filter other liquids, while perhaps not obvious to us, is prevalent in nature. It’s wonderful to see how leveraging nature’s innovation in this manner can potentially lead to huge energy savings,” said Wyss Founding Director Donald Ingber, who is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital, as well as professor of bioengineering at SEAS.

Additional authors of the paper include Yuki Ainge from Northeastern University; Chris Williams and Aubrey Maltz from the University of Waterloo; and Tom Blough and Mughees Khan from the Wyss Institute at Harvard University.

This research was supported by ARPA-E and the National Science Foundation.